Table 1.
Clinical values of patients along the infection. (Reference values: Linfocytes (1.2–5.2), D-Dimer (0–250), LDH (135–225), C-Reactive Protein (0.0–0.5), Ferritin (22–274), IL-6 < 4.3, CD4 (300–1400), IgG (650–1600)).
| Case A | 27/May–15/June | 15/June–30/June | 01/July–15/July | 16/July–30/July | |
| Lymphocytes (×103/µL) | 300 | 700 | 1100 | 600 | |
| D-dimer (ng/mL) | 309 | 286 | 233 | 378 | |
| LDH (U/L) | 262 | 280 | 303 | 418 | |
| C- reactive protein (mg/dL) | 3.2 | 8.3 | 15.9 | 22.4 | |
| Ferritin (µg/L) | 4797 | 3683 | 7504 | 7433 | |
| IL-6 (pg/mL) | 20 | 20.5 | 56.3 | 335 | |
| CD4 (cells/µL) | 86 (23%) | 175 | |||
| IgG (mg/dL) | 545 | 517 | 429 | ||
| SARS-CoV-2 Serology | Negative | Negative | Negative | Negative | |
| Case B | 8/April | 14/May | 12/August | 20/October | |
| Lymphocytes (×103/µL) | 100 | 100 | 400 | 500 | |
| D-dimer (ng/mL) | 581 | 168 | |||
| LDH (U/L) | 374 | 326 | 403 | ||
| C- reactive protein (mg/dL) | 4.1 | 10.3 | 0.5 | 0.3 | |
| Ferritin (µg/L) | 4559 | 2723 | 575 | 50 | |
| IL-6 (pg/mL) | 44.1 | 88.5 | |||
| CD4 (cells/µL) | 17 ( 16%) | 9 (27.3%) | 106(25.7%) | 109(20.8%) | |
| IgG (mg/dL) | 578 | 353 | 1070 | 760 | |
| SARS-CoV-2 Serology | Negative | Negative | Negative | ||
| Case C | 3/April–30/April | 1/May–14/May | 15/May–31/May | 1/June–15/June | 5/July |
| Lymphocytes (×103/µL) | 200 | 300 | 100 | 200 | 100 |
| D-dimer (ng/mL) | 185 | 1007 | 837 | 384 | |
| LDH (U/L) | 203 | 268 | 350 | 246 | 199 |
| C- reactive protein (mg/dL) | 5 | 3.7 | 5.3 | 4.5 | 14.3 |
| Ferritin (µg/L) | 2349 | 2655 | 2637 | 4940 | |
| IL-6 (pg/mL) | 38.4 | 56.1 | 108.4 | ||
| CD4 (cells/µL) | 45 | ||||
| IgG (mg/dL) | 917 | 605 | |||
| SARS-CoV-2 Serology | Negative | Negative | |||